Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Daniel Faggella. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Daniel Faggella or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Accelerate and Mitigate Risk in Clinical Development - with Panos Karelis of Intelligencia AI

21:50
 
Share
 

Manage episode 470580207 series 2728612
Content provided by Daniel Faggella. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Daniel Faggella or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Today’s guest is Panos Karelis, Director of Customer Experience and Insights at Intelligencia AI. Intelligencia AI is a life sciences technology company that uses proprietary data, biomedical expertise, and AI-driven algorithms to assess the probability of technical and regulatory success for drug candidates, helping pharmaceutical companies make informed decisions on which drugs to advance or discontinue. Panos joins us on today’s show to explore the key challenges and opportunities in AI adoption for drug development. He discusses the “black box” problem in AI and the importance of transparency and explainability in building trust. Panos also highlights the role of high-quality, harmonized data in generating accurate AI-driven insights and the mindset shift required for organizations to integrate AI-assisted decision-making successfully. Additionally, he explains how AI can optimize clinical trial design, enhance portfolio management, and improve business development and licensing decisions. This episode is sponsored by Intelligencia AI. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

  continue reading

930 episodes

Artwork
iconShare
 
Manage episode 470580207 series 2728612
Content provided by Daniel Faggella. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Daniel Faggella or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Today’s guest is Panos Karelis, Director of Customer Experience and Insights at Intelligencia AI. Intelligencia AI is a life sciences technology company that uses proprietary data, biomedical expertise, and AI-driven algorithms to assess the probability of technical and regulatory success for drug candidates, helping pharmaceutical companies make informed decisions on which drugs to advance or discontinue. Panos joins us on today’s show to explore the key challenges and opportunities in AI adoption for drug development. He discusses the “black box” problem in AI and the importance of transparency and explainability in building trust. Panos also highlights the role of high-quality, harmonized data in generating accurate AI-driven insights and the mindset shift required for organizations to integrate AI-assisted decision-making successfully. Additionally, he explains how AI can optimize clinical trial design, enhance portfolio management, and improve business development and licensing decisions. This episode is sponsored by Intelligencia AI. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

  continue reading

930 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play